Microbial transformation of Danazol (cas 17230-88-5) with Cunninghamella blakesleeana and anti-cancer activity of Danazol (cas 17230-88-5) and its transformed products

Add time:08/23/2019    Source:sciencedirect.com

Biotransformation of Danazol (cas 17230-88-5) (1) (17β-hydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole) with Cunninghamella blakesleeana yielded three new metabolites 2–4 and a known metabolite 5. These metabolites were identified as 14β,17β-dihydroxy-2-(hydroxymethyl)-17α-pregn-4-en-20-yn-3-one (2), 1α,17β-dihydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole (3), 6β,17β-dihydroxy-17α-pregna-2,4-dien-20-yno-[2,3-d]-isoxazole (4), and 17β-hydroxy-2-(hydroxymethyl)-17α-pregn-1,4-dien-20-yn-3-one (5). Danazol (1) and its derivatives were evaluated against cervical cancer cell line (HeLa). Compound 1 showed a potent cytotoxicity with IC50 = 0.283 ± 0.013 μM, as compared to doxorubicin (IC50 = 0.506 ± 0.015 μM), where compound 3 was also found to be significantly active with IC50 = 13.427 ± 0.819 μM.

We also recommend Trading Suppliers and Manufacturers of Danazol (cas 17230-88-5). Pls Click Website Link as below: cas 17230-88-5 suppliers

Prev:Original StudyDanazol (cas 17230-88-5) as First-Line Therapy for Myelodysplastic Syndrome
Next:Synthesis of 4-haloserotonin derivatives and synthesis of the toad alkaloid Dehydrobufotenine (cas 17232-69-8))